A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Efficacy And Safety Of Barzolvolimab In Patients With Prurigo Nodularis
Posted Date: Nov 6, 2024
- Investigator: Alan Fleischer
- Specialties:
- Type of Study: Drug
The purpose of this study is to evaluate the clinical effect of a new drug on the chronic itch of participants diagnosed with prurigo nodularis
Criteria:
Participants Must Be 18 Years Old Or Older, Have Tried And Failed Treatment With Topical Medication And Suffer From Severe Itching
Keywords:
Nodules Or Bumps, Severe Itchiness, Disrupted Sleep
For More Information:
Jordan Sambrookes
(513) 475-7631
perryj8@ucmail.uc.edu